BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $4.00 thousand for the 12-month period ending 2025-05-31, per its 10-K filed 2025-08-29.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2025-08-29
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $4.00K.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $90.00K, a 0.00% change from fiscal 2022.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $90.00K.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $364.00K, a 318.39% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-05-31 | $4.00K 10-K · filed 2025-08-29 |
| 2023-05-31 | $90.00K 10-K · filed 2024-08-28 |
| 2022-05-31 | $90.00K 10-K · filed 2023-08-25 |
| 2019-05-31 | $364.00K 10-K · filed 2019-08-29 |
| 2018-05-31 | $87.00K 10-K · filed 2019-08-29 |
| 2017-05-31 | $616.00K 10-K · filed 2018-08-29 |
| 2016-05-31 | $256.00K 10-K · filed 2017-08-29 |
| 2015-05-31 | $11.00K 10-K · filed 2016-08-29 |
| 2014-05-31 | $20.00K 10-K · filed 2015-08-31 |
| 2013-05-31 | $70.30K 10-K · filed 2014-08-29 |
| 2012-05-31 | $8.80K 10-K · filed 2013-08-29 |
| 2011-05-31 | $10.20K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |